Users Online:1176
Home
About us
Editorial board
Search
Ahead of print
Current issue
Archives
Submit article
Instructions
Subscribe
Contacts
Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Table of Contents
October-December 2012
Volume 6 | Issue 4
Page Nos. 0-37
Online since Wednesday, September 24, 2014
Accessed 17,733 times.
PDF access policy
Journal allows immediate open access to content in HTML + PDF
View issue as eBook
Author Institution Mapping
Issue statistics
RSS
Show all abstracts
Show selected abstracts
Export selected to
Add to my list
EDITORIAL
Editorial
p. 0
RK Manchanda
HTML Full Text not available
[PDF]
[Sword Plugin for Repository]
Beta
ORIGINAL ARTICLES
Morpho-anatomy of leaf, stem and root of
Alternanthera sessilis
(L.) R. Br. ex DC and
Alternanthera pungens Kunth (Amaranthaceae)
and its significance in drug identification
p. 1
HC Gupta, J Raj, A Rathi, EN Sundaram, S Kumar, RK Manchanda
The present communication deals with morpho-anatomical characters of leaf, stem and root of
Alternanthera sesilis
and
Alternanthera pungens
and its signifinace in identification and differentiation of raw drug originated from these species. The plant characters of diagnostic importance are for example colour of stem is green in
Alternanthera sesilis
and brown in
Alternanthera pungens;
flower of
Alternanthera sesilis
possess three stamens while
Alternanthera pungens
possess five stamens. The study will be useful in confirming the authenticity of raw drug and also serve as a reference for advanced studies of these two such closely related species.
[ABSTRACT]
HTML Full Text not available
[PDF]
[Sword Plugin for Repository]
Beta
A multicentric, double-blind randomized, homoeopathic pathogenetic trial of
Caesalpinia bonducella
p. 8
Rajpal , Vinay Kr. Singh, VA Siddiqui, C Nayak, AK Majumdar, PK Chandra, JP Singh, SD Pathak, G Rakshit
Objective:
To elicit the pathogenetic response of
Caesalpinia bonducella
in homoeopathic potencies on healthy human volunteers.
Methodology:
The drug
Caesalpinia bonducella
was proved by the Central Council for Research in Homoeopathy (CCRH) through randomized, double-blind, placebo-controlled design. The proving was conducted at three centres. The drug was proved in 6 & 30 centesimal potencies on 50 apparently healthy volunteers, declared eligible after their pre-trial medical examinations by the medical specialists and routine laboratory investigations. In first phase of proving, provers were given 56 doses of placebo divided in 04 doses per day for 14 days. In next two phases, 56 doses of pre-selected potencies or placebo as per the randomization were administered in divided doses same as in first phase. The symptoms manifested during the trial period were noted down by the provers and elaborated by the Proving Masters. The generated data of the drug from all three centres were compiled at provingcum- data processing cell of CCRH headquarters after de-coding.
Observations:
Out of 34 provers who were on actual drug trial, only 12 manifested symptoms. Drug was able to manifest symptoms in both the potencies, in more or less every part of the body.
Conclusion:
The pathogenetic response elicited during the proving trial, expands the scope of use of the drug
Caesalpinia bonducella
and will benefit the research scholars and clinicians. The generated symptoms of this drug will carry more value when verified clinically.
[ABSTRACT]
HTML Full Text not available
[PDF]
[Sword Plugin for Repository]
Beta
Homoeopathic individualized LM-potencies versus Centesimal potencies for pain management of cervical spondylosis: A multicenter prospective randomized exploratory clinical study
p. 16
C Nayak, Vikram Singh, Jaya Gupta, Mohd Shahid Ali, Ramendar Pal, MD Arya, P Hima Bindu, Debdatta Nayak, Paromita Goswami
Objective:
Primary objective was to assess the feasibility for a further definite study to compare the effectiveness of LM-vs-CM homoeopathic potencies in reducing pain due to cervical spondylosis.
Method:
A multi center prospective randomized clinical pilot study was conducted by Central Council for Research in Homoeopathy at its three centers during June 2009 - June 2010. Out of 148 patients screened, 56 patients were enrolled and randomized as per the pre-set inclusion criteria. However 54 patients, LM group (n=28) and CM group (n=26) were analyzed. Pain was assessed using visual analog scale. The primary end point for pain from 1 to 60 days was calculated using Area under the curve method. Secondary outcome was to assess the quality of life using WHO QoL Bref questionnaire. Medicines were prescribed to the enrolled patients on the basis of their totality of symptoms and according to principles of homeopathy.
Results:
AUC for pain was significantly less in the LM group [Median (IQR): 112 (86 to 299); p= 0.007] after the prescription of homeopathic medicines. Overall quality of life of the patients after homeopathic medication showed significant improvement in the WHO-BREF domains: Physical, psychological, and Environmental only.
Conclusion:
Homeopathic medicines in LM potencies are better than CM potencies for pain management of cervical spondylosis. Further blinded RCT can be conducted for validation of the results.
[ABSTRACT]
HTML Full Text not available
[PDF]
[Sword Plugin for Repository]
Beta
Clinical Verification of
Ichthyolum
- A multicentric observational study
p. 24
PS Chakraborty, Subhash Kaushik, SS Nain, Pramodji Singh, Ojit Singh, KC Das, Darshan Singh, VK Singh, MK Rai, PK Pradhan
Introduction:
Ichthyolum
is reported to have pronounced action on various systemic affections in various literatures. On the basis of this literature, Council conducted a thorough proving on this drug earlier and subsequently clinical verification, to ascertain its clinical importance in Homoeopathy.
Objectives:
The primary objective was to clinically verify the symptomatology of
Ichthyolum
as observed during its proving conducted by Council on this drug and the secondary objective was to ascertain the clinical symptoms.
Method:
In the multicentre study, a total of 131 patients from all age groups & both sexes were enrolled from the O.P.D.s of the respective institutes & units of the Council. If
Ichthyolum
was found to be the similimum or covering maximum number of symptoms of the patient, the case was enrolled. The medicine was prescribed in different potencies as per the need of the case and in accordance with the homoeopathic principles. The progress was noted in a predefined follow up sheet to determine the effects of the medicine.
Result:
It was found that 35 symptoms including 22 symptoms elicited during drug proving were verified, along with a good number of clinical symptoms, which were relieved completely or partially, exploring the wider area of the medicine for its therapeutic use.
Conclusion:
Ichthyolum
can be considered as an important medicine for Acne, Conjunctivitis, Constipation, Coryza, Cracked Lips, Dysentery, Eczema, Flatulence, Headache, Insomnia, Nausea, Psoriasis, Restlessness, Tonsillitis & Vertigo. The noted clinical symptoms are acne and scaly eruptions on whole body specially on joints, burning after itching, warts and polydypsia. All these verified symptoms confirm the scope of its therapeutic action.
[ABSTRACT]
HTML Full Text not available
[PDF]
[Sword Plugin for Repository]
Beta
REMINISCENCES
CCRH Quarterly Bulletin (1982)
p. 34
SR Sharma
HTML Full Text not available
[PDF]
[Sword Plugin for Repository]
Beta
BOOK REVIEW
Pharmacological Actions of Homoeopathic Drugs
p. 37
Eswara Das
HTML Full Text not available
[PDF]
[Sword Plugin for Repository]
Beta
Feedback
Subscribe
Next Issue
Previous Issue
Sitemap
|
What's New
|
Feedback
|
Disclaimer
© Indian Journal of Research in Homoeopathy | Published by Wolters Kluwer -
Medknow
Online since 05 July, 2013